Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
D000583:Amikacin / Q000494:pharmacology; D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D002981:Clindamycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D006801:Humans; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D009162:Mycobacterium avium / Q000187:drug effects*; D009428:Netilmicin / Q000494:pharmacology; D009170:Nontuberculous Mycobacteria / Q000187:drug effects; D014031:Tobramycin / Q000494:pharmacology
D000904:Antibiotics, Antitubercular; D002981:Clindamycin; D009428:Netilmicin; D000583:Amikacin; D008034:Lincomycin; D014031:Tobramycin